Quality of life of the patients with chronic prostatitis under the influence of complex balneopeloid and enzyme therapy with Longidase
- Authors: Mkrtchyan M.A.1, Gusova B.A.2, Emkuzhev K.E.2, Kaisinova A.S.1,2, Bobrik Y.V.3
-
Affiliations:
- North Caucasian Federal Scientific and Clinical Center
- Pyatigorsk Medical and Pharmaceutical Institute – branch of the Volgograd State Medical University
- S.I. Georgievsky Medical Academy V.I. Vernadsky Crimean Federal University
- Issue: Vol 22, No 2 (2023)
- Pages: 73-79
- Section: Original studies
- URL: https://journals.rcsi.science/1681-3456/article/view/251425
- DOI: https://doi.org/10.17816/321299
- ID: 251425
Cite item
Abstract
BACKGROUND: In modern medicine, among the main indicators of the effectiveness of therapeutic measures, the quality of life of the patient is singled out, which allows determining the degree of recovery of physical and mental health after treatment of acute conditions.
AIM: to evaluate the effectiveness of complex balneopeloid and enzyme therapy with longidase according to the monitoring of the quality of life of the patients suffering from chronic bacterial prostatitis.
MATERIALS AND METHODS: There have been observed 54 patients with chronic prostatitis. They were divided into 2 groups by simple randomization: in the comparison group (n=26) the patients were prescribed exercise therapy, internal and external administration of mineral water of Zheleznovodsk type, peloidotherapy with silt sulfide mud topically, antibiotic therapy with ceftriaxone, phytomicroclysters; in the main group (n=28), the patients additionally underwent antibiotic and enzyme therapy by peripheral indirect lymphotropic therapy. The efficiency was assessed using validated Quality of Life questionnaires: Chronic Prostatitis Symptom Scale (NIH-CPS) and SF-36 General Health Questionnaire (Social Functioning-36).
RESULTS: The analysis of the clinical effect of the new treatment technology revealed its advantage over the standardized therapy, which is proven by the monitoring of QoL indicators for 1 year after the spa treatment: recovery of QoL in the main group immediately after the treatment occurred by 59.7% (p <0.01), 6 months later ― by 72.7% (p <0.01), with a slight decrease in the rate in 12 months ― by 64.9% (p <0.01). The dynamics of physical and mental health indicators on the SF-36 scale was also observed with the same degree of confidence: compared with the baseline, the average improvement was 25.5% (p <0.01), 33.6% (p <0.01) and 27.3% (p <0.01) respectively. In the comparison group, the dynamics of indicators for all NIH-CPSI and SF-36 scales was also significant, but lower than similar indicators in the main group by 23–25% on average (p <0.01) and 12–15%, respectively.
CONCLUSION: The results of the study indicate the high effectiveness of complex balneopeloid and lymphotropic therapy with the patients suffering from chronic prostatitis at the stage of spa treatment.
Full Text
##article.viewOnOriginalSite##About the authors
Mesrop A. Mkrtchyan
North Caucasian Federal Scientific and Clinical Center
Email: jk.mam@skfmba.ru
ORCID iD: 0000-0003-2300-4496
Russian Federation, Yessentuki
Berta A. Gusova
Pyatigorsk Medical and Pharmaceutical Institute – branch of the Volgograd State Medical University
Email: b.a.gusova@yandex.ru
ORCID iD: 0000-0001-5979-9185
SPIN-code: 8808-7356
MD, Cand. Sci. (Med.)
Russian Federation, PyatigorskKasim E. Emkuzhev
Pyatigorsk Medical and Pharmaceutical Institute – branch of the Volgograd State Medical University
Email: kasius888@mail.ru
ORCID iD: 0000-0003-4569-0546
SPIN-code: 3115-4875
MD, Cand. Sci. (Med.)
Russian Federation, PyatigorskAgnessa S. Kaisinova
North Caucasian Federal Scientific and Clinical Center; Pyatigorsk Medical and Pharmaceutical Institute – branch of the Volgograd State Medical University
Author for correspondence.
Email: zamoms@skfmba.ru
ORCID iD: 0000-0003-1199-3303
SPIN-code: 6552-9684
MD, Dr. Sci. (Med.)
Russian Federation, Yessentuki; PyatigorskYury V. Bobrik
S.I. Georgievsky Medical Academy V.I. Vernadsky Crimean Federal University
Email: yura.bobrik@mail.ru
ORCID iD: 0000-0003-1505-4506
SPIN-code: 2478-2563
MD, Dr. Sci. (Med.), Professor
Russian Federation, SimferopolReferences
- Brizhatyuk EV, Shevchenko SY. Influence of the lifestyle of a patient with chronic prostatitis on its quality. Urology Herald. 2020;8(3):13–17. (In Russ). doi: 10.21886/2308-6424-2020-8-3-13-17
- Russian clinical recommendations. Urology. Ed. by Yu.G. Alyaeva, P.V. Glybochko, D.Yu. Pushkar. Moscow: GEOTAR-Media; 2016. 480 р. (In Russ).
- Tyuzikov IA, Grekov EA. Chronic prostatitis/chronic pelvic pain: Modern trends and prospects for treatment from the standpoint of evidence-based medicine. Experimental clin urology. 2022;(1):24–29. (In Russ). doi: 10.29188/2222-8543-2022-15-1-90-100
- Magri VM, Boltri CT, Colombo R, et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019;90(4):227–248. doi: 10.4081/aiua.2018.4.227
- Pushkar DI, Gvozdev MI, Tupikina NV. Questionnaires as a tool for assessing the quality of life in urogynecological patients. Russ Bulletin Obstetrician-Gynecologist. 2013;13(1):23-29. (In Russ).
- Mkrtchyan AM, Kaisinova AS, Kocharian GV. Balneoploid and lymphotropic therapy in medical rehabilitation of patients with chronic prostatitis. Resort Med. 2015;(1):70–75. (In Russ).
- Sanatorium-resort treatment: National Guide. Ed. by A.N. Razumov, V.I. Starodubov, G.N. Ponomarenko. Moscow: GEOTAR-Media; 2021. 752 р. (In Russ).
- Starokozhko LE, Chebotarev VV, Krasheninnikov VL, Gaidamak II. Assessment of the effectiveness of rectal candles on a hydrophilic basis for chronic bacterial prostatitis. Med News North Caucasus. 2012;25(1):70–72. (In Russ).
- Ter-Akopov GN, Efimenko NV, Glukhov AN, Kaisinova AS. On the development of programs and new medical technologies for sanatorium-resort treatment and medical rehabilitation in the Federal State Budgetary Institution of the SKFNCS FBBA of Russia. Resort Med. 2022;(1):5–15. doi: 10.51871/2304-0343_2022_1_5
- Talberg PI, Mazina SE, Andryukhin MI. Complex therapy of chronic prostatitis. Modern Problems Sci Education. 2015;(4):415. (In Russ).
- Vinnik YY, Kuzmenko AV, Giaurgiev TA. Treatment of chronic prostatitis: Current state of the problem. Urology. 2021;(4):138–144. (In Russ). doi: 10.18565/urology.2021.4.138-144
- Kurortology of the Caucasian mineral waters. Vol. 1. Ed. by V.V. Uyba. Pyatigorsk: Publishing House; 2010. Р. 146–195. (In Russ).
- Semkin VA, Nadtochny AG, Vozgoment OV, Ivanova AA. Limfatic therapy and its significance in the complex treatment of patients. Dentistry. 2020;99(5):116–121. (In Russ). doi: 10.17116/stomat202099051116
- Avdoshin VP, Andryukhin MI, Mikhailikov TG, Pulbere SA. The experience of using the drug Longidase in the complex therapy of chronic prostatitis. Health and education in the 21st century. 2006;8(1):16. (In Russ).
- Zaitsev AV, Khodyreva LA, Dudareva AA, Pushkar DY. A modern view of the use of enzyme preparations in patients with chronic prostatitis. Clin Dermatol Venereol. 2016;15(3):53–60. (In Russ). doi: 10.17116/klinderma201615353-60
- Kulchavenya EV, Shvetsova OP, Breusov AA. Justification of the appointment and effectiveness of the drug Longidase in patients with chronic prostatitis. Urology. 2018;(4):64–71. (In Russ). doi: 10.18565/urology.2018.4:64-71
![](/img/style/loading.gif)